Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.03.2019 | Clinical study

Acute liver injury with agomelatine and other antidepressants

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Agomelatine does not appear to be associated with an increased risk of hospitalisation due to acute liver injury (ALI) compared to citalopram, according to study results reported in CNS Drugs, nor is there generally an association with other antidepressants. …
Fußnoten
1
EUPAS10446
 
2
amitriptylline, duloxetine, escitalopram, fluoxetine, mirtazapine, paroxetine, sertraline, venlafaxine
 
Literatur
Zurück zum Zitat Pladevall-Vila M, et al. Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources. CNS Drugs : 4 Mar 2019. Available from: URL: https://doi.org/10.1007/s40263-019-00611-9 Pladevall-Vila M, et al. Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources. CNS Drugs : 4 Mar 2019. Available from: URL: https://​doi.​org/​10.​1007/​s40263-019-00611-9
Metadaten
Titel
Acute liver injury with agomelatine and other antidepressants
Publikationsdatum
01.03.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-58908-4

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Cabozantinib

Case report

Alprostadil

Case report

Alisertib